Article Text
Therapeutics/Prevention
Systematic review with meta analysis
Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes
Statistics from Altmetric.com
Footnotes
Competing interests DWJ has previously received consultancy fees, research grants, speaker's honoraria and travel sponsorships from Amgen, Roche and Janssen-Cilag.
Provenance and peer review Commissioned; internally peer reviewed.